Transient Receptor Potential Vanilloid Type-1 Channel in Cardiometabolic Protection

참고문헌 (66)

1. Wyne KL, "Preventing cardiovascular disease and diabetes: a call to action from the ADA and AHA", Journal of the CardioMetabolic Syndrome, 1, pp.220~221 (2006)
2. Eckel RH, "Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association", Circulation, 113, pp.2943~2946 (2006)
3. Brunzell JD, "Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation", Diabetes Care, 31, pp.811~822 (2008)
4. Plutzky J, "Preventing type 2 diabetes and cardiovascular disease in metabolic syndrome: the role of PPARalpha", Diabetes and Vascular Disease Research, 4(3), pp.12~14 (2007)
5. American Heart Association Nutrition Committee, "Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee", Circulation, 114, pp.82~96 (2006)
6. Bibbins-Domingo K, "Projected effect of dietary salt reductions on future cardiovascular disease", The New England Journal of Medicine, 362, pp.590~599 (2010)
7. Shin KO, "Alterations of autonomic nervous activity and energy metabolism by capsaicin ingestion during aerobic exercise in healthy men", Journal of Nutritional Science and Vitaminology (Tokyo), 53, pp.124~132 (2007)
8. Ahuja KD, "Effects of chili consumption on postprandial glucose, insulin, and energy metabolism", American Journal of Clinical Nutrition, 84, pp.63~69 (2006)
9. Wahlqvist ML, "Wattanapenpaiboon N. Hot foods-unexpected help with energy balance", Lancet, 358, pp.348~349 (2001)
10. Yang D, "Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension", Cell Metabolism, 12, pp.130~141 (2010)
11. Zhang LL, "Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity", Circulation Research, 100, pp.1063~1070 (2007)
12. Caterina MJ, "The capsaicin receptor: a heat-activated ion channel in the pain pathway", Nature, 389, pp.816~824 (1997)
13. Nagy I, "The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology", European Journal of Pharmacology, 500, pp.351~369 (2004)
14. Sessa WC, "A new way to lower blood pressure: pass the chili peppers please!", Cell Metabolism, 12, pp.109~110 (2010)
15. Gunthorpe MJ, "Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms", Current Pharmaceutical Design, 14, pp.32~41 (2008)
16. Luo D, "Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide", Regulatory Peptides, 150, pp.66~72 (2008)
17. Sudhahar V, "Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries", European Journal of Pharma, 607, pp.143~150 (2009)
18. Franco-Cereceda A, "Resiniferatoxin-, capsaicin- and CGRP-evoked porcine coronary vasodilatation is independent of EDRF mechanisms but antagonized by CGRP(8-37)", Acta Physiologica Scandina, 143, pp.331~337 (1991)
19. Deng PY, "Calcitonin gene-related peptide and hypertension", Peptides, 26, pp.1676~1685 (2005)
20. g PY, "Role of calcitonin gene-related peptide in the phenol-induced neurogenic hypertension in rats", 119, pp.155~161 (2004)
21. White CB, "Arteriolar dilation mediated by capsaicin and calcitonin gene-related peptide in rats", American Journal of Physiology, 265, pp.1411~1415 (1993)
22. Li J, "High-salt-induced increase in blood pressure: role of capsaicin-sensitive sensory nerves", Journal of Hypertension, 21, pp.577~582 (2003)
23. Poblete IM, "Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed", Journal of Physiology, 568, pp.539~551 (2005)
24. Bratz IN, "Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome", American Journal of Physiology - Heart and Circulatory Physiology, 294, pp.2489~2496 (2008)
25. Hao X, "TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice", Pflugers Arch, 461, pp.345~353 (2011)
26. Wang DH, "The vanilloid receptor and hypertension", Acta Pharmacologica Sinica, 26, pp.286~294 (2005)
27. Wang Y, "Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet", Journal of Pharmacology and Experimental Therapeutics, 321, pp.763~769 (2007)
28. Qin XP, "Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats", Journal of Cardiovascular Pharmacology, 50, pp.654~659 (2007)
29. Wang Y, "Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension", Hypertension, 52, pp.264~270 (2008)
30. Sexton A, "12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia", reperfusion injury via activation of neuronal TRPV1, 2007, pp.21, 2695~2703
31. Wang L, "TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice", Circulation, 112, pp.3617~3623 (2005)
32. Li YJ, "Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts", European Journal of Pharmacology, 311, pp.163~167 (1996)
33. Huang W, "Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction", Hypertension, 53, pp.243~250 (2009)
34. Zhong B, "TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice", American Journal of Physiology - Heart and Circulatory Physiology, 293, pp.1791~1798 (2007)
35. Akiba Y, "Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats", Biochemical and Biophysical Research Communications, 321, pp.219~225 (2004)
36. Tolan I, "The effect of capsaicin on blood glucose, plasma insulin levels and insulin binding in dog models", Phytotherapy Research, 15, pp.391~394 (2001)
37. 김추숙, "Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages", FEBS LETTERS, 581(23), pp.4389~4396, ELSEVIER SCIENCE BV
38. Domotor A, "Capsaicin and glucose absorption and utilization in healthy human subjects", European Journal of Pharmacology, 534, pp.280~283 (2006)
39. van de Wall EH, "Ablation of capsaicin-sensitive afferent nerves affects insulin response during an intravenous glucose tolerance test", Life Science, 77, pp.1283~1292 (2005)
40. Karlsson S, "Capsaicin-induced sensory denervation increases glucose elimination in rodents", Diabetologia, 42, pp.260~261 (1999)
41. Razavi R, "TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes", Cell, 127, pp.1123~1135 (2006)
42. Gram DX, "Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes", European Journal of Neuroscience, 25, pp.213~223 (2007)
43. Gram DX, "Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV", European Journal of Pharmacology, 509, pp.211~217 (2005)
44. Suri A, "The emerging role of TRPV1 in diabetes and obesity", Trends in Pharmacological Science, 29, pp.29~36 (2008)
45. Guillot E, "Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in diabetic rats", Life Science, 59, pp.969~977 (1996)
46. Xin H, "Vanilloid receptor expressed in the sarcoplasmic reticulum of rat skeletal muscle", Biochemical and Biophysical Research Communications, 332, pp.756~762 (2005)
47. Castro J, "A small component of the endoplasmic reticulum is required for store-operated Ca2+ channel activation in liver cells: evidence from studies using TRPV1 and taurodeoxycholic acid", Biochemical Journal, 418, pp.553~566 (2009)
48. Manjunatha H, "Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats", Canadian Journal of Physiology and Pharmacology, 85, pp.588~596 (2007)
49. Tani Y, "Effects of capsinoid on serum and liver lipids in hyperlipidemic rats", Journal of Nutritional Science and Vitaminology (Tokyo), 50, pp.351~355 (2004)
50. 이철호, "SHORT-TERM CONTROL OF CAPSAICIN ON BLOOD AND OXIDATIVE STRESS OF RATS IN VIVO", PHYTOTHER RES, 17, pp.454~458, Phytother. Res.
51. Kawada T, "Effects of capsaicin on lipid metabolism in rats fed a high fat diet", Journal of Nutrition, 116, pp.1272~1278 (1986)
52. Kahn-Kirby AH, "Specific polyunsaturated fatty acids drive TRPV-dependent sensory signaling in vivo", Cell, 119, pp.889~900 (2004)
53. Matta JA, "TRPV1 is a novel target for omega-3 polyunsaturated fatty acids", Journal of Physiology, 578, pp.397~411 (2007)
54. Liu M, "TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors", European Journal of Neuroscience, 24, pp.1~6 (2006)
55. Melnyk A, "Resistance to aging-associated obesity in capsaicin-desensitized rats one year after treatment", Obesity Research, 3, pp.337~344 (1995)
56. Herman RM, "Prevalence of somatic small fiber neuropathy in obesity", International Journal of Obesity (Lond), 31, pp.226~235 (2007)
57. Motter AL, "TRPV1-null mice are protected from diet-induced obesity", FEBS Letters, 582, pp.2257~2262 (2008)
58. Pare M, "Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes", Journal of Comparative Neurology, 501, pp.543~567 (2007)
59. Kawada T, "Capsaicin-induced beta-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization", Proceedings of the Society for Experimental Biology and Medicine, 183, pp.250~256 (1986)
60. Kim KM, "Increase in swimming endurance capacity of mice by capsaicin- induced adrenal catecholamine secretion", Bioscience, Biotechnology, and Biochemistry, 61, pp.1718~1723 (1997)
61. Ohnuki K, "Administration of capsiate, a non-pungent capsaicin analog, promotes energy metabolism and suppresses body fat accumulation in mice", Bioscience, Biotechnology, and Biochemistry, 65, pp.2735~2740 (2001)
62. Leung FW, "Capsaicin-sensitive intestinal mucosal afferent mechanism and body fat distribution", Life Science, 83, pp.1~5 (2008)
63. Inoue N, "Enhanced energy expenditure and fat oxidation in humans with high BMI scores by the ingestion of novel and non-pungent capsaicin analogues (capsinoids)", Bioscience, Biotechnology, and Biochemistry, 71, pp.380~389 (2007)
64. Wang X, "Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1", Journal of Physiology, 564, pp.541~547 (2005)
65. Hwang JT, "Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase", Biochemical and Biophysical Research Communications, 338(2), pp.694~699, Academic Press
66. Masuda Y, "Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog", Journal of Applied Physiology, 95, pp.2408~2415 (2003)

관련 논문AI추천